Showing 1 - 15 results of 15 for search 'Aik-Choon Tan', query time: 0.06s
Refine Results
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
Drepmel—A Multi-Omics Melanoma Drug Repurposing Resource for Prioritizing Drug Combinations and Understanding Tumor Microenvironment by Zachary J. Thompson, Jamie K. Teer, Jiannong Li, Zhihua Chen, Eric A. Welsh, Yonghong Zhang, Noura Ayoubi, Zeynep Eroglu, Aik Choon Tan, Keiran S. M. Smalley, Yian Ann Chen
Published 2022-09-01
Article -
9
A tyrosine kinase inhibitor-induced interferon response positively associates with clinical response in EGFR-mutant lung cancer by Natalia J. Gurule, Caroline E. McCoach, Trista K. Hinz, Daniel T. Merrick, Adriaan Van Bokhoven, Jihye Kim, Tejas Patil, Jacob Calhoun, Raphael A. Nemenoff, Aik Choon Tan, Robert C. Doebele, Lynn E. Heasley
Published 2021-05-01
Article -
10
PATH-SURVEYOR: pathway level survival enquiry for immuno-oncology and drug repurposing by Alyssa N. Obermayer, Darwin Chang, Gabrielle Nobles, Mingxiang Teng, Aik-Choon Tan, Xuefeng Wang, Y. Ann Chen, Steven Eschrich, Paulo C. Rodriguez, G. Daniel Grass, Soheil Meshinchi, Ahmad Tarhini, Dung-tsa Chen, Timothy I. Shaw
Published 2023-06-01
Article -
11
Grading of lung adenocarcinomas with simultaneous segmentation by artificial intelligence (GLASS-AI) by John H. Lockhart, Hayley D. Ackerman, Kyubum Lee, Mahmoud Abdalah, Andrew John Davis, Nicole Hackel, Theresa A. Boyle, James Saller, Aysenur Keske, Kay Hänggi, Brian Ruffell, Olya Stringfield, W. Douglas Cress, Aik Choon Tan, Elsa R. Flores
Published 2023-07-01
Article -
12
Real-world pan-cancer landscape of frameshift mutations and their role in predicting responses to immune checkpoint inhibitors in cancers with low tumor mutational burden by Ignacio Garrido-Laguna, Asaf Maoz, Wungki Park, Abdul Rafeh Naqash, Vaia Florou, Breelyn Wilky, Jonathan Trent, Umang Swami, Garrett Frampton, Heloisa P Soares, Sonam Puri, Aik Choon Tan, Charalampos S Floudas, Carter Norton, Ethan S Sokol, Peter Hosein, Gilberto de Lima Lopes
Published 2023-08-01
Article -
13
Pre-Treatment Mutational and Transcriptomic Landscape of Responding Metastatic Melanoma Patients to Anti-PD1 Immunotherapy by Carol M. Amato, Jennifer D. Hintzsche, Keith Wells, Allison Applegate, Nicholas T. Gorden, Victoria M. Vorwald, Richard P. Tobin, Kelsey Nassar, Yiqun G. Shellman, Jihye Kim, Theresa M. Medina, Matthew Rioth, Karl D. Lewis, Martin D. McCarter, Rene Gonzalez, Aik-Choon Tan, William A. Robinson
Published 2020-07-01
Article -
14
151 Genetic heterogeneity between paired primary and metastatic solid tumors and implications for neoantigen-based personalized cancer vaccines by Xuefeng Wang, Igor Puzanov, Abdul Rafeh Naqash, Paulo C Rodriguez, George J Weiner, Jose Conejo-Garcia, Jamie Teer, Xiaoqing Yu, Margaret E Gatti-Mays, William Dalton, Howard Colman, Aik Choon Tan, Timothy I Shaw, Darwin Chang, Alyssa Obermayer, Dale Hedges, Aakrosh Ratan, Martin D McCarter, John Carpten, Susanne M Arnold, Michelle Churchman
Published 2023-11-01Article -
15
898 Demonstration of the utility of real-world progression-free survival (rwPFS) by application of an IFN-γ-related signature in a real-world cohort of patients with melanoma by Xuefeng Wang, Igor Puzanov, Abdul Rafeh Naqash, Ahmad A Tarhini, George J Weiner, Phaedra Agius, Margaret E Gatti-Mays, Howard Colman, Aik Choon Tan, Issam El Naqa, Timothy I Shaw, Aakrosh Ratan, Martin D McCarter, John Carpten, Susanne M Arnold, Michelle Churchman, Michael D Radmacher, Oliver A Hampton, David M McKean, Daniel R Elgort, Robert J Rounbehler, Donghai Dai, Tingyi Li, William S Dalton
Published 2023-11-01Article